The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe
Open accessAbstract
BACKGROUND: Little is known about the incidence and risk factors for serious non-AIDS-defining events. METHODS: The incidence of non-AIDS events (malignancies, end-stage renal disease, liver failure, pancreatitis, cardiovascular disease), and AIDS after January 1, 2001, was calculated; Poisson regression was used to investigate factors associated with non-AIDS and AIDS. RESULTS: Among 12,844 patients, 1058 were diagnosed with a non-AIDS event [incidence 1.77 per 100 person-years of follow-up; 95% confidence interval (CI): 1.66 to 1.87]; 462 patients (43.7%) died. The incidence of AIDS (1025 diagnoses; 339 deaths, 33.1%) was 1.72 per 100 person-years of follow-up (1.61 to 1.83). After adjustment, older age [incidence rate ratio (IRR): 1.71 per 10 years older, 95% CI: 1.60 to 1.83], diabetes (IRR: 1.49, 95% CI: 1.22 to 1.82) and hypertension (IRR: 1.63, 95% CI: 1.43 to 1.87) were associated with non-AIDS events. Compared with patients without an event, there was a 4-fold increased risk of death after an AIDS event (relative hazard: 4.14; 95% CI 3.47 to 4.94) and almost a 7-fold increased risk of death after a non-AIDS event (relative hazard: 6.72; 95% CI: 5.61 to 8.05). CONCLUSIONS: Non-AIDS events were common in the combination antiretroviral therapy era and associated with considerably mortality. Evidence on the impact of modifying immunodeficiency and lifestyle-related factors on the risk of non-AIDS events in HIV-infected persons is an important but unmet research need.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes
Gæde, P., Vedel, P., Larsen, N., Jensen, G. V. H., Parving, H.-H., & Pedersen, O. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021778 · Cited by 4,378
Castro, K. G., Ward, J. W., Slutsker, L., Buehler, J. W., Jaffe, H. W., Berkelman, R. L., & Curran, J. W. (1993) · Clinical Infectious Diseases · doi:10.1093/clinids/17.4.802 · Cited by 4,349
CD4+ Count–Guided Interruption of Antiretroviral Treatment
(2006) · New England Journal of Medicine · doi:10.1056/nejmoa062360 · Cited by 2,231
Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
(2003) · New England Journal of Medicine · doi:10.1056/nejmoa030218 · Cited by 1,678
Gallant, J. E. (2004) · JAMA · doi:10.1001/jama.292.2.191 · Cited by 1,341
Changing patterns of mortality across Europe in patients infected with HIV-1
Mocroft, A., Vella, S., Benfield, T., Chiesi, A., Miller, V, Gargalianos, P., Monforte, A. D., Yust, I., Bruun, J., Phillips, A., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)03201-2 · Cited by 1,270
Self-citationDecline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A., & Lundgren, J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
Self-citationLiver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus: The D:A:D Study
(2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.15.1632 · Cited by 1,113
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704
(2010) · Clinical Infectious Diseases · doi:10.1086/652283 · Cited by 594
Gupta, S. K., Eustace, J. A., Winston, J. A., Boydstun, I. I., Ahuja, T. S., Rodriguez, R. A., Tashima, K. T., Roland, M., Franceschini, N., Palella, F. J., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/430257 · Cited by 581
Guiguet, M., Boué, F., Cadranel, J., Lang, J.-M., Rosenthal, E., & Costagliola, D. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70282-7 · Cited by 571
AIDS across Europe, 1994–98: the EuroSIDA study
Mocroft, A., Katlama, C., Johnson, A., Pradier, C., Antunes, F., Mulcahy, F., Chiesi, A., Phillips, A., Kirk, O., & Lundgren, J. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02504-6 · Cited by 453
Self-citationSackoff, J. E., Hanna, D. B., Pfeiffer, M. R., & Torian, L. V. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-6-200609190-00003 · Cited by 451
Sullivan, P. S., Hanson, D. L., Chu, S. Y., Jones, J. L., Ward, J. W., & Disease Group, T. A. S. O. (1998) · Blood · doi:10.1182/blood.v91.1.301 · Cited by 433
Mocroft, A., Kirk, O., Barton, S. E., Dietrich, M., Proenca, R., Colebunders, R., Pradier, C., Monforte, A. D., Ledergerber, B., & Lundgren, J. D. (1999) · AIDS · doi:10.1097/00002030-199905280-00010 · Cited by 411
Self-citationInterleukin-2 Therapy in Patients with HIV Infection
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0903175 · Cited by 381
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infection
Baker, J. V., Peng, G., Rapkin, J., Abrams, D. I., Silverberg, M. J., MacArthur, R. D., Cavert, W. P., Henry, W. K., & Neaton, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3282f7cb76 · Cited by 372
Lewden, C., May, T., Rosenthal, E., Burty, C., Bonnet, F., Costagliola, D., Jougla, E., Semaille, C., Morlat, P., Salmon, D., et al. (2008) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31817efb54 · Cited by 342
Fontas, E., van Leth, F., Sabin, C. A., Friis‐Møller, N., Rickenbach, M., d’Arminio Monforte, A., Kirk, O., Dupon, M., Morfeldt, L., Mateu, S., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/381783 · Cited by 337
Self-citationCrum-Cianflone, N., Hullsiek, K. H., Marconi, V., Weintrob, A., Ganesan, A., Barthel, R. V., Fraser, S., Agan, B. K., & Wegner, S. (2009) · AIDS · doi:10.1097/qad.0b013e328317cc2d · Cited by 278
The role of HIV in serious diseases other than AIDS.
Phillips, A. N., Neaton, J., & Lundgren, J. D. (2008) · AIDS · doi:10.1097/qad.0b013e3283174636 · Cited by 269 · cited 1×
“However, as patients with HIV live longer, there is an increasing focus on so-called non-AIDS events.(4,5) Patients may have an increased risk of non-AIDS comorbidity (non– HIV-associated or non-AIDS comorbidity), many of which are associated with aging.”
BackgroundSelf-citationAnemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies
Volberding, P. A., Levine, A. M., Dieterich, D., Mildvan, D., Mitsuyasu, R., Saag, M., & for the Anemia in HIV Working Group (2004) · Clinical Infectious Diseases · doi:10.1086/383031 · Cited by 267
Levin, A. (2003) · Seminars in Dialysis · doi:10.1046/j.1525-139x.2003.16025.x · Cited by 261
Predictors of proteinuria and renal failure among women with HIV infection
Szczech, L. A., Gange, S. J., van der Horst, C., Bartlett, J. A., Young, M., Cohen, M. H., Anastos, K., Klassen, P. S., & Svetkey, L. P. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00094.x · Cited by 241
Phillips, A. N., Carr, A., Neuhaus, J., Visnegarwala, F., Prineas, R., Burman, W. J., Williams, I., Drummond, F., Duprez, D., Belloso, W. H., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300215 · Cited by 240
Self-citationLaboratory control values for CD4 and CD8 T lymphocytes. Implications for HIV-1 diagnosis
BOFILL, M., JANOSSY, G., LEE, C. A., MACDONALD-BURNS, D., PHILLIPS, A. N., SABIN, C., TIMMS, A., JOHNSON, M. A., & KERNOFF, P. B. A. (2008) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb03068.x · Cited by 223
Self-citationThe Strategies for Management of Antiretroviral Therapy (SMART) Study Group (2008) · The Journal of Infectious Diseases · doi:10.1086/529523 · Cited by 204
Neuhaus, J., Angus, B., Kowalska, J. D., Rosa, A. L., Sampson, J., Wentworth, D., & Mocroft, A. (2010) · AIDS · doi:10.1097/qad.0b013e3283365356 · Cited by 178
Self-citationStaging of Chronic Kidney Disease
Bauer, C. A., Melamed, M. L., & Hostetter, T. H. (2008) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010110 · Cited by 137
Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?
Mocroft, A., Soriano, V., Rockstroh, J. K., Reiss, P., Kirk, O., Wit, S. D., Gatell, J. M., Clotet, B., Phillips, A. N., & Lundgren, J. D. (2005) · AIDS · doi:10.1097/01.aids.0000194799.43799.ea · Cited by 133
Self-citationLau, B. M., Gange, S. J., & Moore, R. D. (2006) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/01.qai.0000247229.68246.c5 · Cited by 119
Dragsted, U. B., Gerstoft, J., Pedersen, C., Peters, B. S., Duran, A. S., Obel, N., Castagna, A., Cahn, P. E., Clumeck, N., Bruun, J. N., et al. (2003) · The Journal of Infectious Diseases · doi:10.1086/377288 · Cited by 118
Self-citationAntiretroviral Therapy Cohort Collaboration (ART-CC) (2009) · Clinical Infectious Diseases · doi:10.1086/597468 · Cited by 114
Zangerle, R., Sarcletti, M., Gallati, H., Reibnegger, G. J., WACHTER, H., & Fuchs, D. (1994) · PubMed · Cited by 97
The UK Collaborative HIV Cohort Study Steering Committee (2007) · AIDS · doi:10.1097/qad.0b013e32827038bf · Cited by 94
Harris, R., Sterne, J. A. C., Abgrall, S., Dabis, F., Reiss, P., Saag, M. S., Phillips, A. N., Chêne, G., Gill, M. J., Justice, A. C., et al. (2008) · Antiviral Therapy · doi:10.1177/135965350801300802 · Cited by 87
Self-citationMontes, M., Pulido, F., Barrós, C., et al. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki063 · Cited by 81
Podlekareva, D. N., Mocroft, A., Dragsted, U. B., Ledergerber, B., Beniowski, M., Lazzarin, A., Weber, J. N., Clumeck, N., Vetter, N., Phillips, A. N., et al. (2006) · The Journal of Infectious Diseases · doi:10.1086/506366 · Cited by 79
Self-citationBonnet, F., Chêne, G., Thiébaut, R., Dupon, M., Lawson‐Ayayi, S., Pellegrin, J., Dabis, F., Morlat, P., & (GECSA), F. T. G. D. C. D. S. E. A. (2007) · HIV Medicine · doi:10.1111/j.1468-1293.2007.00508.x · Cited by 66
Factors associated with chronic renal failure in HIV-infected ambulatory patients
Krawczyk, C. S., Holmberg, S. D., Moorman, A. C., Gardner, L. I., & McGwin, G. (2004) · AIDS · doi:10.1097/00002030-200411050-00009 · Cited by 60
Moore, R. D., Gebo, K. A., Lucas, G. M., & Keruly, J. C. (2008) · Clinical Infectious Diseases · doi:10.1086/592115 · Cited by 59
Smith, C. J., Olsen, C. H., Mocroft, A., et al. (2008) · AIDS · doi:10.1097/qad.0b013e3282f03094 · Cited by 48
Self-citationMourad, J.-J., & Le Jeune, S. (2008) · Journal of Hypertension · doi:10.1097/01.hjh.0000334072.97080.33 · Cited by 41
What is so bad about a hemoglobin level of 12 to 13 g/dL for chronic kidney disease patients anyway?
Besarab, A., Frinak, S., & Yee, J. (2009) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2008.12.007 · Cited by 34
Sharma, S., Gage, B. F., Deych, E., & Rich, M. W. (2009) · American Heart Journal · doi:10.1016/j.ahj.2009.03.009 · Cited by 34
Causes of death in HIV infection
Mocroft, A., Gatell, J. M., Reiss, P., Ledergerber, B., Kirk, O., Vella, S., Blaxhult, A., Phillips, A. N., & Lundgren, J. D. (2004) · AIDS · doi:10.1097/00002030-200411190-00018 · Cited by 34
Self-citationCancer-related anaemia management in the 21st century
Pronzato, P. (2006) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.04.008 · Cited by 26
Cited by
Murray, D. D., Suzuki, K., Law, M., Trebicka, J., Neuhaus, J., Wentworth, D., Johnson, M., Vjecha, M. J., Kelleher, A. D., Emery, S., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0139981 · Cited by 2,740
Self-citationShah, A. S. V., Stelzle, D., Lee, K. K., Beck, E. J., Alam, S., Clifford, S., Longenecker, C. T., Strachan, F., Bagchi, S., Whiteley, W., et al. (2018) · Circulation · doi:10.1161/circulationaha.117.033369 · Cited by 975
Thompson, M. A., Mugavero, M. J., Amico, K. R., Cargill, V. A., Chang, L. W., Gross, R., Orrell, C., Altice, F. L., Bangsberg, D. R., Bartlett, J. G., et al. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-156-11-201206050-00419 · Cited by 582
Residual Immune Dysregulation Syndrome in Treated HIV infection
Lederman, M. M., Funderburg, N. T., Sekaly, R. P., Klatt, N. R., & Hunt, P. W. (2013) · Advances in Immunology · doi:10.1016/b978-0-12-407707-2.00002-3 · Cited by 348
Rodriguez-Penney, A. T., Iudicello, J. E., Riggs, P. K., Doyle, K., Ellis, R. J., Letendre, S. L., Grant, I., & Woods, A. T. H. N. (2013) · AIDS Patient Care and STDs · doi:10.1089/apc.2012.0329 · Cited by 309
Metadata
- Authors
- Mocroft, A., Reiss, P., Gasiorowski, J., Ledergerber, B., Kowalska, J., Chiesi, A., Gatell, J., Rakhmanova, A., Johnson, M., Kirk, O., & Lundgren, J.
- Venue
- JAIDS Journal of Acquired Immune Deficiency Syndromes
- Published
- 2010-10-01
- Volume
- 55
- Issue
- 2
- Pages
- 262-270
- ISSN
- 1525-4135 (ISSN-L)
- OpenAlex
- W2076675316
- Cited by
- 274
- References
- 49
- FWCI
- 29.09
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.